JPRN-UMIN000000550已完成2 期
Multicenter phase II study of docetaxel and cisplatin as primary chemotherapy in patients with stage Ic-IV epithelial ovarian cancer - Phase II study of docetaxel and cisplatin in patients with epithelial ovarian cancer
A group for a study of DOC/CDDP combination chemotherapy for ovarian cancer0 个研究点目标入组 100 人开始时间: 2006年12月18日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 100
研究概览
简要总结
Presented at the 44th Annual Meeting of Japan Society of Clinical Oncology (October 18th to 20th 2006)
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- Female
入选标准
- 未提供
排除标准
- •1.Received only exploratory laparotomy 2.Confirmed infection 3.Fever (a body temperature >= 38 degrees Celsius) 4.Severe complication 5.Active concomitant malignancy 6.Brain metastasis 7.Interstitial pneumonia or lung fibrosis confirmed by chest X-ray or computed tomography 8.Pleural or peritoneal effusion that required treatment 9.Pericardial effusion 10.Motor paralysis, peripheral nervous system dysfunction or edema of grade 2 or more 11.History of severe drug allergy 12.Previously received long-term corticosteroid therapy 13.Pregnant or lactating women, or women who intended to become pregnant during the study
研究者
相似试验
已完成
2 期
Multicenter phase II study of docetaxel/cisplatin/bevacizumab combination therapy in patients with advanced non-squamous non-small cell lung cancer (TORG1016)JPRN-UMIN000004368Thoracic Oncology Research Group47
招募中
不适用
Phase I/II study of bi-weekly docetaxel and cisplatin plus S-1 (bi-weekly DCS) as first-line therapy for advanced esophageal cancer.Esophageal cancerJPRN-UMIN000032257The University of Tokyo50
招募中
1 期
Phase I/II study of bi-weekly DCS as first-line therapy for advanced esophageal cancer.Esophageal cancerJPRN-jRCTs031180376Seto Yasuyuki38
终止
2 期
Docetaxel + Doxorubicin as Neoadjuvant Chemotherapy in Patients With Breast CancerDuctal CarcinomaNCT00461344Sanofi20
进行中（未招募）
不适用
Multicenter phase II study evaluating docetaxel, CDDP, and cetuximab as induction regimen prior to surgery in chemonaive patients with NSCLC stage IB, II, and IIIA. - INN06eoadjuvant treatment of non-small lung cancerEUCTR2006-004639-31-ATTAKO